Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases EDITORIAL COMMENT

被引：0
|
作者：
Tu, Shi-Ming [1 ]
Chen, Adrienne H. [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX USA
来源：
CANADIAN JOURNAL OF UROLOGY | 2012年 / 19卷 / 03期
关键词：
CONTROLLED-TRIAL; ACID;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6268 / 6268
页数：1
相关论文
共 50 条
  • [1] Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases
    Tunn, Ulf W.
    Stenzl, Amulf
    Schultze-Seemann, Wolfgang
    Strauss, Arne
    Kindler, Manfred
    Miller, Kurt
    Wirth, Manfred P.
    Zantl, Niko
    Schulze, Matthias
    May, Christoph
    Ruebel, Amelie
    Birkholz, Katrin
    Gruenwald, Viktor
    CANADIAN JOURNAL OF UROLOGY, 2012, 19 (03) : 6261 - 6267
  • [2] Radiotherapy combined with zoledronate can reduce skeletal-related events in renal cell carcinoma patients with bone metastasis
    Hosaka, Seiichi
    Katagiri, Hirohisa
    Niwakawa, Masashi
    Harada, Hideyuki
    Wasa, Junji
    Murata, Hideki
    Takahashi, Mitsuru
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (06) : 1127 - 1133
  • [3] Radiotherapy combined with zoledronate can reduce skeletal-related events in renal cell carcinoma patients with bone metastasis
    Seiichi Hosaka
    Hirohisa Katagiri
    Masashi Niwakawa
    Hideyuki Harada
    Junji Wasa
    Hideki Murata
    Mitsuru Takahashi
    International Journal of Clinical Oncology, 2018, 23 : 1127 - 1133
  • [4] Bisphosphonates in prevention and control of skeletal-related events in cancer patients with bone metastases
    Drosik, Kazimierz
    Krzakowski, Maciej
    Jarosz, Jerzy
    Kraj, Maria
    Krzemieniecki, Krzysztof
    Pienkowski, Tadeusz
    Utracka-Hutka, Beata
    Jassem, Jacek
    Szczylik, Cezary
    Wojtukiewicz, Marek
    Ziobro, Marek
    ONCOLOGY IN CLINICAL PRACTICE, 2006, 2 (04): : 152 - 164
  • [5] Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases
    Sun, Jong-Mu
    Ahn, Jin Seok
    Lee, Soohyeon
    Kim, Jung A.
    Lee, Jeeyun
    Park, Yeon Hee
    Park, Hee Chul
    Ahn, Myung-Ju
    Ahn, Yong Chan
    Park, Keunchil
    LUNG CANCER, 2011, 71 (01) : 89 - 93
  • [6] Exploiting machine learning for predicting skeletal-related events in cancer patients with bone metastases
    Wang, Zhiyu
    Wen, Xiaoting
    Lu, Yaohong
    Yao, Yang
    Zhao, Hui
    ONCOTARGET, 2016, 7 (11) : 12612 - 12622
  • [7] The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer
    Delea, T
    Langer, C
    McKiernan, J
    Liss, M
    Edelsberg, J
    Brandman, J
    Sung, J
    Raut, M
    Oster, G
    ONCOLOGY, 2004, 67 (5-6) : 390 - 396
  • [8] Statins may decrease skeletal-related events in breast cancer patients with bone metastases
    Dincer, Murat
    Bulut, Nilufer
    Harputluoglu, Hakan
    Altundag, Kadri
    MEDICAL HYPOTHESES, 2006, 67 (05) : 1146 - 1147
  • [9] Clinical and economic impact of skeletal-related events in breast cancer patients with bone metastases
    Carter, J.
    Kaura, S.
    Botteman, M.
    BREAST, 2011, 20 : S78 - S78
  • [10] Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases.
    Sun, J.
    Ahn, J.
    Lee, J.
    Park, Y.
    Lee, S.
    Ahn, M.
    Park, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345